ArticleTherapeutic advances in medical oncology2023

Immune repertoire and responses to neoadjuvant TCHP therapy in HER2-positive breast cancer.

Junyoung Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.